Hematopoietic abnormalities in mice deficient in gp130-mediated STAT signaling

Experimental Hematology

Volumn 30, Issue 11, 2002, Pages 1248-1256

  Jenkins, Brendan J ^a,c   Quilici, Cathy ^a   Roberts, Andrew W ^b   Grail, Dianne ^a   Dunn, Ashley R ^a   Ernst, Matthias ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; FLUOROURACIL; GLYCOPROTEIN GP 130; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 11; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; RECOMBINANT ERYTHROPOIETIN; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; STEM CELL FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BONE MARROW CELL; CARBOXY TERMINAL SEQUENCE; CELL COUNT; CELL CULTURE; CELL MATURATION; CELL SIZE; CELL STIMULATION; COLONY FORMING UNIT S; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DRUG EFFECT; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; LEUKOCYTOSIS; MEGAKARYOCYTE; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; WILD TYPE;

AGE FACTORS; ANIMALS; ANTIGENS, CD; BINDING SITES; BONE MARROW; CELL COUNT; CELL DIFFERENTIATION; CELL SIZE; COLONY-FORMING UNITS ASSAY; CYTOKINE RECEPTOR GP130; DNA-BINDING PROTEINS; DRUG RESISTANCE; GROWTH INHIBITORS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HEMATOPOIETIC SYSTEM; INTERLEUKIN-11; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LYMPHOKINES; MEGAKARYOCYTES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MULTIPOTENT STEM CELLS; RECOMBINANT PROTEINS; SEQUENCE DELETION; SIGNAL TRANSDUCTION; SPLEEN; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; THROMBOCYTOPENIA; TRANS-ACTIVATORS;

EID: 0036839954     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(02)00929-3     Document Type: Article

References (33)

1. Kishimoto T., Akira S., Narazaki M., Taga T. Interleukin-6 family of cytokines and gp130. Blood. 86:1995;1243.
2. Peters M., Muller A.M., Rose-John S. Interleukin-6 and soluble interleukin-6 receptor. direct stimulation of gp130 and hematopoiesis Blood. 92:1998;3495.
3. Ikebuchi K., Wong G.G., Clark S.C.et al. Interleukin 6 enhancement of interleukin 3-dependent proliferation of multi-potential hemopoietic progenitors. Proc Natl Acad Sci U S A. 84:1987;9035.
4. Tsuji K., Lyman S.D., Sudo T., Clark S.C., Ogawa M. Enhancement of murine hematopoiesis by synergistic interactions between steel factor (ligand for c-kit), interleukin-11, and other early acting factors in culture. Blood. 79:1992;2855.
5. Keller J.R., Gooya J.M., Ruscetti F.W. Direct synergistic effects of leukemia inhibitory factor on hematopoietic progenitor cell growth. comparison with other hematopoietins that use the gp130 receptor subunit Blood. 88:1996;863.
6. Ishibashi T., Kimura H., Uchida T.et al. Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro. Proc Natl Acad Sci U S A. 86:1989;5953.
7. Burstein S.A., Mei R.L., Henthorn J., Friese P., Turner K. Leukemia inhibitory factor and interleukin-11 promote maturation of murine and human megakaryocytes in vitro. J Cell Physiol. 153:1992;305.
8. Wallace P.M., MacMaster J.F., Rillema J.R.et al. Thrombocytopoietic properties of oncostatin M. Blood. 86:1995;1310.
9. Imai T., Koike K., Kubo T.et al. Interleukin-6 supports human megakaryocytic proliferation and differentiation in vitro. Blood. 78:1991;1969.
10. Broudy V.C., Lin N.L., Kaushansky K. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood. 85:1995;1719.
11. Metcalf D., Hilton D.J., Nicola N.A. Leukemia inhibitory factor can potentiate murine megakaryocyte production in vitro. Blood. 77:1991;2150.
12. Metcalf D., Nicola N.A., Gearing D.P. Effects of injected leukemia inhibitory factor on hematopoietic and other tissues in mice. Blood. 76:1990;50.
13. Ishibashi T., Kimura H., Shikama Y.et al. Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood. 74:1989;1241.
14. Neben T.Y., Loebelenz J., Hayes L.et al. Recombinant human interleukin-11 stimulates megakaryocytopoiesis and increases peripheral platelets in normal and splenectomized mice. Blood. 81:1993;901.
15. Leonard J.P., Quinto C.M., Kozizta M.K., Neben T.Y., Goldman S.J. Recombinant human interleukin-11 stimulates multi-lineage hematopoietic recovery in mice after a myelosuppressive regimen of sublethal irradiation and carboplatin. Blood. 83:1994;1499.
16. Yoshida K., Taga T., Saito M.et al. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci U S A. 93:1996;407.
17. Betz U.A., Bloch W., van den Broek M.et al. Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects. J Exp Med. 188:1998;1955.
18. Murakami M., Hibi M., Nakagawa N.et al. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science. 260:1993;1808.
19. Hilton D.J., Hilton A.A., Raicevic A.et al. Cloning of a murine IL-11 receptor α-chain. requirement for gp130 for high affinity binding and signal transduction EMBO J. 13:1994;4765.
20. Gearing D.P., Thut C.J., VandeBos T.et al. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J. 10:1991;2839.
21. Mosley B., De Imus C., Friend D.et al. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem. 271:1996;32635.
22. Gerhartz C., Heesel B., Sasse J.et al. Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. I. Definition of a novel phosphotyrosine motif mediating STAT. 1(activation. J Biol Chem 271):1996;12991.
23. Fukada T., Hibi M., Yamanaka Y.et al. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130. involvement of STAT3 in anti-apoptosis Immunity. 5:1996;449.
24. Ernst M., Inglese M., Waring P.et al. Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation. J Exp Med. 194:2001;189.
25. Yeager A.M., Levin J., Levin F.C. The effects of 5-fluorouracil on hematopoiesis. studies of murine megakaryocyte-CFC, granulocyte-macrophage-CFC, and peripheral blood cell levels Exp Hematol. 11:1983;944.
26. Peters M., Schirmacher P., Goldschmitt J.et al. Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice. J Exp Med. 185:1997;755.
27. Escary J.L., Perreau J., Dumenil D., Ezine S., Brulet P. Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation. Nature. 363:1993;361.
28. Bernad A., Kopf M., Kulbacki R.et al. Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system. Immunity. 1:1994;725.
29. Ware C.B., Horowitz M.C., Renshaw B.R.et al. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development. 121:1995;1283.
30. Nakajima K., Yamanaka Y., Nakae K.et al. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J. 15:1996;3651.
31. Yamanaka Y., Nakajima K., Fukada T., Hibi M., Hirano T. Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation. EMBO J. 15:1996;1557.
32. Ohtani T., Ishihara K., Atsumi T.et al. Dissection of signaling cascades through gp130 in vivo. reciprocal roles for STAT3- and SHP2-mediated signals in immune responses Immunity. 12:2000;95.
33. Zhang Y.Y., Vik T.A., Ryder J.W.et al. Nf1 regulates hematopoietic progenitor cell growth and ras signaling in response to multiple cytokines. J Exp Med. 187:1998;1893.